Journal of Allergy and Clinical Immunology: Global (Feb 2024)

Allogeneic hematopoietic stem cell transplantation outcome in oldest known surviving patients with Wiskott-Aldrich syndrome

  • Ariharan Anantharachagan, MBChB, MRCP, MsC,FRCPath,
  • Sook Yin Loh, MBBCh, MRCP,
  • Siobhan O. Burns, MB PhD,
  • Arian Laurence, PhD, MRCP, FRCPath,
  • Susan Tadros, MBBS, BSc, MRCP, FRCPath,
  • Eleni Tholouli, MD, PhD,
  • Yadanar Lwin, MBBS, MMed (Infn, Imm), FRACP, FRCPA,
  • Nicolas Martinez-Calle, MD, PhD,
  • P. Vaitla, MBBS, MRCP, FRCPath,
  • Emma C. Morris, PhD, FMedSci

Journal volume & issue
Vol. 3, no. 1
p. 100191

Abstract

Read online

Regardless of their age, adult patients with Wiskott-Aldrich syndrome should be considered for hematopoietic stem cell transplantation if clinically indicated.

Keywords